drugset / Trial / NCT05670847

Exogenous Ketone Esters for Drug Resistant Epilepsy

NCT05670847 ↗

Phase 2/3 Recruiting 60 enrolled Sohag University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to investigate the efficacy of add-on exogenous ketone esters for treating children with drug-resistant epilepsy

Timeline

Start
2023-01-10
Primary completion
2025-06-30
Completion
2025-07-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Exogenous ketone ester Unknown 500 mg/kg Oral

Indications